| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.7M | +82.2% |
| SG&A Expense | $10.2M | +49.4% |
| Operating Income | -$19.7M | -57.8% |
| Interest Expense | $711K | -23.7% |
| Income Tax | $0 | — |
| Net Income | -$20.3M | -51.3% |
| EPS (Basic) | -$0.77 | +30.6% |
| EPS (Diluted) | -$0.77 | +30.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.1M | -1.5% |
| Current Assets | $21.8M | +10.6% |
| Total Assets | $23.9M | +8.6% |
| Current Liabilities | $11.9M | +101.9% |
| Long-term Debt | $3.8M | -24.4% |
| Total Liabilities | $17.4M | +56.3% |
| Stockholders' Equity | $6.4M | -40.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | -26.2% |
| Investing Cash Flow | -$759K | -825.6% |
| Financing Cash Flow | $13.5M | -34.1% |